Cargando…
EPH68 Epidemiological Impact of Generalized SARS-COV-2 Vaccination of Children Aged 5 to 11
Autores principales: | Leleu, H, Blachier, M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747418/ http://dx.doi.org/10.1016/j.jval.2022.09.990 |
Ejemplares similares
-
EPH121 Future Trends of the COVID-19 Pandemics: What Should We Expect?
por: Leleu, H, et al.
Publicado: (2022) -
EPH53 The Role of Incentives- Parents’ Intention to Vaccinate Their 5- to 11-Year-Old Children with the COVID-19 Vaccine in Israel
por: Shmueli, L
Publicado: (2022) -
Author Correction: A stochastic agent-based model of the SARS-CoV-2 epidemic in France
por: Hoertel, Nicolas, et al.
Publicado: (2020) -
Anti-Sars-CoV-2 vaccination campaign in children aged 5-11 years: the experience of a mass vaccination center in the city of Milan
por: Astorri, Elisa, et al.
Publicado: (2023) -
Audiological and vestibular symptoms following SARS-CoV-2 infection and COVID-19 vaccination in children aged 5–11 years
por: Aldè, Mirko, et al.
Publicado: (2023)